Director of Hematological Malignancies Translational Research

Director of Hematological Malignancies Translational Research

Company/Institution:Mass General Brigham Cancer Institute

Department:Division of Hematology/Oncology; Department of Medicine

Location:Boston, MA, USA

$300,000 or above

June 22, 2026

June 22-July 22, 2026

The Mass General Brigham (MGB) Cancer Institute currently seeks applications for the inaugural Director of Hematological Malignancies Translational Research.

The Director of Hematological Malignancies Translational Research will provide senior leadership for the Mass General Brigham Cancer Institute’s precision oncology research mission in hematologic malignancies. This senior role is responsible for advancing a comprehensive translational research enterprise that seamlessly integrates genomic diagnostics, measurable residual disease (MRD) assessment, and biomarker-driven science with clinical care delivery and innovative clinical trial design across the leukemia, lymphoma, myeloma, and bone marrow transplant programs.

The Director will establish and lead an independently funded research program, while serving as a key institutional representative in national and international collaborations. Working in close partnership with clinical and scientific leadership, the Director will play a central role in translating scientific discoveries into meaningful clinical impact. Equally important, the Director will foster a vibrant academic environment by recruiting, mentoring, and developing junior faculty, postdoctoral fellows, medical students, and other trainees, building a strong and sustainable pipeline of future physician-scientists in translational malignant hematology research.

The successful candidate will have a strong record of independently funded translational research in hematologic malignancies, along with demonstrated leadership in multi-center clinical trial correlative science and national or international recognition. The ideal candidate will show a commitment to mentorship and a proven ability to lead collaborative, multi-institutional research efforts. Expertise in precision diagnostics, including MRD detection and genomic profiling—and experience leading large-scale translational programs or consortia are essential. Experience engaging with regulatory bodies, contributing to clinical guideline development, and building strategic partnerships with industry and foundation sponsors is preferred.

The role also includes maintaining a clinical role as Attending Physician in Malignant Hematology. This is a five-year-term position, renewable for a second term.

Appointment as a Professor or Associate Professor of Medicine, full-time, at the Harvard Medical School will be commensurate with experience, training and achievements in addition to teaching activities.Suitable candidates will have an MD, MD-PhD, or equivalent and board certification in Hematology, Hematology-Oncology, or equivalent.

Applicants are invited to submit a letter of interest and curriculum vitae to: [email protected]

We are an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability status, protected veteran status, gender identity, sexual orientation, pregnancy and pregnancy-related conditions or any other characteristic protected by law.

It is unlawful in Massachusetts to require or administer a lie detector test as a condition of employment or continued employment. An employer who violates this law shall be subject to criminal penalties and civil liability.

How to Apply

Applicants are invited to submit a letter of interest and curriculum vitae to: [email protected]

Please title the email: Director of Hematological Malignancies Translational Research Application

Contact Information

Stephanie DiModica
55 Fruit Street
Boston, MA 02114 USA
[email protected]